FMR LLC 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-12 11:13 am Sale | 2022-09-09 | 13G | AGIOS PHARMACEUTICALS INC AGIO | FMR LLC | 2,007,111 3.661% | -3,427,202 (-63.07%) | Filing |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | AGIOS PHARMACEUTICALS INC AGIO | FMR LLC | 5,434,313 10.006% | -2,199,667 (-28.81%) | Filing |